Develops a total artificial heart designed to fully replace native heart function for patients with severe end-stage heart failure.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
BiVACOR is a preclinical stage medical device company developing the BiVACOR Total Artificial Heart (TAH), the first long-term therapy for patients with severe heart failure. The TAH is designed to replace the complete function of the native heart and address the global unmet need of patients with end-stage heart failure (HF) by providing a life-extending solution.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
BiVACOR Management Team
Investors
Cormorant Asset Management
OneVentures
BiVACOR Valuations & Financials
View real-time NPM data on BiVACOR stock including daily BiVACOR stock price estimates, valuation history, and historical share price information. Access BiVACOR financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track BiVACOR pricing across six independent market signals. Looking for private company due diligence data sources on BiVACOR? Get in touch to learn more.
Similar Companies
like BiVACOR
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
TRexBio
Healthcare & Life Sciences
Develops therapeutics for immune diseases by analyzing tissue and computational biology to identify drug targets that restore immune balance.
Etiome
Develops stage-specific therapies that target disease progression early, aiming to prevent debilitating and irreversible health outcomes.
Healthie
Healthcare & Life Sciences
Digital healthcare platform providing practice management and EHR solutions with integrated scheduling, billing, and telehealth services.
Merlin Labs
Industrials
Develops the Merlin Pilot, an autonomous flight system for aircraft, aiming for uncrewed operations in military and civilian sectors.
Lumen Bioscience
Develops affordable, orally delivered biologic drugs using spirulina to treat diseases like C. difficile and inflammatory bowel disease.
Luna Physical Therapy
Healthcare & Life Sciences
Mobile platform connecting patients with licensed physical therapists for personalized in-home treatment and virtual exercise support.
Pintu
Leading Indonesian cryptocurrency trading platform enabling users to buy, sell, and manage digital assets through a secure mobile interface.
FAQ
We have answers
BiVACOR stock does not trade on public stock exchanges. BiVACOR stock is considered a private security and you need to be an accredited investor to trade shares. To invest in BiVACOR stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
BiVACOR Stock does not trade on public stock exchanges. In order to sell BiVACOR shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
BiVACOR does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view BiVACOR share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for BiVACOR stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell BiVACOR stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in BiVACOR stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
BiVACOR is a private company and has not had an IPO. There is currently no BiVACOR IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to BiVACOR IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
